TCBWMS
RDHL

Texas Capital Bank Wealth Management Services’s Redhill Biopharma RDHL Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37
Closed -$19K – 177
2022
Q3 		$19K Buy
+37
New +$32.2K ﹤0.01% 148

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's RDHL Position: Q4 2022 in Review

Texas Capital Bank Wealth Management Services sold out of Redhill Biopharma (RDHL) in Q4 2022, closing a stake of 37 shares — an estimated $19K sold.

Texas Capital Bank Wealth Management Services first reported a position in RDHL in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 37 funds tracked by Wall St. Rank hold RDHL as of Q4 2022.

  • Texas Capital Bank Wealth Management Services reported no remaining Redhill Biopharma position as of Q4 2022 after selling out during the quarter.
  • Texas Capital Bank Wealth Management Services sold 37 Redhill Biopharma shares in Q4 2022, an estimated $19K.
  • Texas Capital Bank Wealth Management Services first reported a position in Redhill Biopharma in Q3 2022 and held it in 1 quarter.
  • Texas Capital Bank Wealth Management Services's Redhill Biopharma position peaked at $19K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2022.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q4 2022, filed 9 Feb 2023.